Literature DB >> 31027977

A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Rα antibody and TNFα inhibitor.

Hideyasu Yamada1, Norihito Hida2, Yuko Kurashima3, Hiroaki Satoh4, Takefumi Saito5, Nobuyuki Hizawa6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31027977     DOI： 10.1016/j.alit.2019.04.003

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  2 in total

1.  Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia.

Authors:  Hiroki Kawabata; Minoru Satoh; Kazuhiro Yatera
Journal:  J Asthma Allergy       Date:  2021-11-26

2.  Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients.

Authors:  Yoshimasa Hachisu; Yasuhiko Koga; Shu Kasama; Kyoichi Kaira; Masakiyo Yatomi; Haruka Aoki-Saito; Hiroaki Tsurumaki; Yosuke Kamide; Noriaki Sunaga; Toshitaka Maeno; Tamotsu Ishizuka; Takeshi Hisada
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.